Search for: "WYETH PHARMACEUTICALS COMPANY"
Results 401 - 420
of 547
Sorted by Relevance
|
Sort by Date
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
29 Dec 2011, 6:53 am
Wyeth Pharmaceuticals, 797 F. [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
23 Jul 2010, 7:28 am
Mutual Pharmaceutical Co., 659 F. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog) Ruminations… [read post]
6 Nov 2014, 5:00 am
Wyeth, 705 S.E.2d 828 (W. [read post]
5 Feb 2013, 11:32 am
Wyeth Pharmaceuticals, 797 F. [read post]
1 May 2008, 11:21 am
One of the ways we feed this blog is doing what comes naturally to us lawyers - reading recent cases - and hoping that something inspires us. [read post]
8 Nov 2007, 12:21 pm
[PDF] Eastman Kodak Company [PDF] Eli Lilly and Company [PDF] IBM Corporation [DOC] Microsoft Corporation [DOC] Wyeth [DOC] C. [read post]
31 Oct 2013, 5:00 am
The facts sound rather like Wyeth v. [read post]
12 Sep 2023, 9:42 am
Pharmaceutical startups and those in the tech industry have been among those most reported. [read post]
4 Nov 2010, 1:24 pm
Wyeth Pharmaceuticals, 2010 WL 3431671 (E.D. [read post]
28 Nov 2011, 4:02 am
Big pharmaceutical companies have wiped out most of the potential claims against them except for the “failure to warn,” and that’s a particularly tricky claim. [read post]
16 Apr 2012, 1:37 pm
Wyeth Pharmaceuticals, 797 F. [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
